Lanthanide(III) containing nanoparticles as targeted diagnostic and therapeutic agents

First Page		Document Content
Date: 2011-05-11 09:03:38 Neuroimaging Medical specialties Radiology Magnetic resonance imaging Molecular imaging Positron emission tomography Single-photon emission computed tomography Tomography Preclinical imaging Medicine Medical physics Medical imaging		Lanthanide(III) containing nanoparticles as targeted diagnostic and therapeutic agents Add to Reading List Source URL: www.tnw.tudelft.nl Download Document from Source Website File Size: 61,98 KB Share Document on Facebook

	What Is PET? Positron Emission Tomography (PET) is a non-invasive form of medical imaging approved by Medicare for diagnosis and management of several forms of cancer including: Lung Cancer DocID: 1uv0l - View Document
	Determining the diagnostic kinetics of viral encephalitis using positron emission tomography (PET) in Münster Nicholas King, Discipline of Pathology, Bosch Institute, School of Medical Sciences, Sydney Medical School, U DocID: 1rQ7R - View Document
	Histopathologic Features that Influence the Detection of Occult Lymph Node Metastasis Using PET/CT Imaging with Anti-PSMA Df-IAB2M in Newly Diagnosed High Risk Prostate Cancer Patients. 89Zr- Bernard M. Gburek1, Anthony DocID: 1rqYg - View Document
	THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO DocID: 1riLo - View Document
	Microsoft Word - 25-32_FINAL_SN0302.doc DocID: 1rbdW - View Document